ForeverLabs
servicesprovidersmission
Schedule a consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: IBD / Crohn's / Colitis
AI generated image for: Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course
Clinical
Aug 11, 2025
1 min read
PubMed
Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course
MSCs offer a promising emerging therapy for patients with IBD due to their immunosuppressive properties, ability to migrate to areas of injury, and demonstration of colonic healing.
Biological agingIBD / Crohn's / Colitis

Stay in touch

Shop

Annual planLifetime PlanClient Login

Learn

ArticlesBlogFAQ

Careers

About usPrivacy PolicyPressTerms of Service

For Clinics

Scheduler LoginFor PhysiciansPartner With UsContact Us
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTube

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.